10.1056/NEJMoa2413258 89 SawadaN.AdachiK.NakamuraN.MiyabeM.ItoM.KobayashiS.et al (2020)
We dont yet have studies on the long-term effects of GLP-1 therapies in teens, so young patients taking them are practically participants in a research study. Whats more, Cooper and others say, GLP-1s are already being prescribed off label to children under age 12
4 in 10 consider it an immediate concern and intend to offer in 2024
The diverse chemical structure also explains the unique binding pattern of DPP-4 inhibitors [112]
Key elements of nutritional priorities to support GLP-1 therapy users for obesity 27
Interestingly, some of them are able to cross the bloodbrain barrier and act on the brain to stimulate satiety [2], which leads to food intake reduction and, consequently, body weight loss, which occurs at the expense of fat mass